
In This Issue . . .
All Providers:
Chiropractors:
Community Alternatives Program Providers:
Dental Providers:
Durable Medical Equipment Providers:
Home Health Agencies:
Hospice Providers:
Hospitals:
Independent Practitioner Program Providers:
Local Education Agencies:
Mental Health Providers:
Nursing Facility Providers:
Optometrists:
Osteopaths:
Physicians:
Private Duty Nursing Providers:
Podiatrists:
Prescribers and Pharmacy Providers:
Seminars on general Medicaid billing guidelines are scheduled for January 2005. Registration information and a list of dates and site locations for the seminars will be published in the December 2004 general Medicaid bulletin.
EDS, 1-800-688-6696 or 919-851-8888
Information related to the implementation of the new Medicaid Management Information System, NCLeads, scheduled for implementation in mid 2006 can be found online at http://ncleads.dhhs.state.nc.us. Please refer to this website for information, updates, and contact information related to the NCLeads system.
Thomas Liverman, Provider Relations
Office of MMIS Services
919- 855-3112
All providers participating in the Medicaid program are required to submit to the Division of Medical Assistance (DMA), Third Party Recovery Section a quarterly Credit Balance Report indicating balances due to Medicaid. Providers must report any outstanding credits owed to Medicaid that have not been reported previously on a Medicaid Credit Balance Report. However, hospital and nursing facility providers are required to submit a report every calendar quarter even if there are no credit balances. The report must be submitted no later than 30 days following the end of the calendar quarter (March 31, June 30, September 30, and December 31).
The Medicaid Credit Balance Report is used to monitor and recover "credit balances" owed to the Medicaid program. A credit balance results from an improper or excess payment made to a provider. For example, refunds must be made to Medicaid if a provider is paid twice for the same service (e.g., by Medicaid and a medical insurance policy, by Medicare and Medicaid, by Medicaid and a liability insurance policy, if the patient liability was not reported in the billing process or if computer or billing errors occur).
For the purpose of completing the report, a Medicaid Credit Balance is the amount determined to be refundable to the Medicaid program. When a provider receives an improper or excess payment for a claim, it is reflected in the provider’s accounting records (patient accounts receivable) as a "credit." However, credit balances include money due to Medicaid regardless of its classification in a provider's accounting records. If a provider maintains a credit balance account for a stipulated period (e.g., 90 days) and then transfers the account or writes it off to a holding account, this does not relieve the provider of liability to the Medicaid program. The provider is responsible for identifying and repaying all monies owed the Medicaid program.
The Medicaid Credit Balance Report requires specific information on each credit balance on a claim-by-claim basis. The reporting form provides space for 15 claims but may be reproduced as many times as necessary to accommodate all the credit balances being reported. Specific instructions for completing the report are on the reverse side of the reporting form.
Submitting the Medicaid Credit Balance Report does not result in the credit balances automatically being reimbursed to the Medicaid program. A check is the preferred form of satisfying the credit balances; the check must be made payable to EDS and sent to EDS with the required documentation for a refund. If an adjustment is to be made to satisfy the credit balance, an adjustment form must be completed and submitted to EDS with all the supporting documentation for processing.
|
Submit |
Submit |
Submit |
|
Third Party Recovery Section |
EDS |
EDS |
Submit only the completed Medicaid Credit Balance Report to DMA. Do not send refund checks or adjustment forms to DMA. Do not send the Credit Balance Report to EDS. Failure to submit a Medicaid Credit Balance Report will result in the withholding of Medicaid payments until the report is received.
Anita Ray, Third Party Recovery Section
DMA, 919-647-8100
Effective with date of service August 16, 2004, the Medicaid maximum reimbursement rate for the following Community Alternatives Program (CAP) services was increased. This was an interim rate increase that will be effective through December 2004. Results from a pending audit of PCS providers may result in a subsequent rate change. Providers are to be notified of any further rate changes in future general Medicaid bulletins.
ReimbursementIn addition, S5150 HQ, CAP-MR/DD Respite Care (group of 2 to 3 clients) has been revised effective October 1, 2004 to $2.74 per 15 minute unit.
|
Procedure Code
|
Description |
Reimbursement Rate |
|---|---|---|
|
T1000 |
CAP/C Nursing Services |
$9.11/15 min unit |
|
T1005TD |
CAP/AIDS Respite Care – Nursing Level RN |
$9.11/15 min unit |
|
T1005TE |
CAP/AIDS Respite Care – Nursing Level LPN |
$9.11/15 min unit |
|
T1005TD |
CAP-MR/DD Respite Care – Nursing Level RN |
$9.11/15 min unit |
|
T1005TE |
CAP-MR/DD Respite Care – Nursing Level LPN |
$9.11/15 min unit |
Pat Jeter, Rate Setting
DMA, 919-855-4200
Effective with date of service October 1, 2004, the following dental procedure codes have been added to the NC Medicaid Dental Program. These additions were published on September 1, 2004 in Special Bulletin VI: Dental Services Coverage Policy and Billing Guidelines.
|
CDT-4 |
|
Reimbursement |
|---|---|---|
|
D0170 |
Re-evaluation – limited, problem focused *use as a follow-up exam for a specific problem that has been evaluated previously using D0140 *document in the patient’s chart the nature of the emergency and the treatment provided |
$20.00 |
|
D1204 |
Topical application of fluoride (prophylaxis not included) – adult *limited to recipients 13 through 20 years old |
$15.44 |
|
D3230 |
Pulpal therapy (resorbable filling) – anterior, primary tooth *limited to recipients under age 6 *not allowed for the same tooth on the same date of service as D3220 |
$150.00 |
|
D3240 |
Pulpal therapy (resorbable filling) – posterior, primary tooth *limited to recipients under age 9 *allowed for primary second molars only *not allowed for the same tooth on the same date of service as D3220 |
$200.00 |
|
D3320 |
Bicuspid (excluding final restoration) *limited to recipients under age 21 *not allowed for the same tooth on the same date of service as D3220 |
$259.57 |
The following procedure codes were end-dated effective with date of service September 30, 2004.
|
Procedure code |
Description |
|---|---|
|
D2910 |
Recement inlay |
|
D2920 |
Recement crown |
|
D3110 |
Pulp cap – direct (excluding final restoration) |
In addition, the following changes are effective with date of service October 1, 2004:
Providers are reminded to bill their usual and customary charges rather than the Medicaid rate. For coverage criteria and additional billing guidelines, please refer to Clinical Coverage Policy 4A, Dental Services.
Dr. Ron Venezie, Dental Director
DMA, 919-855-4280
The Division of Medical Assistance (DMA) has a new website for the NC Medicaid Dental Program located at http://www.dhhs.state.nc.us/dma/dental.htm. This website includes links to the current dental and orthodontic policy manuals as well as the current dental fee schedule. You also will find a list of frequently asked questions, instructions for the Automated Voice Response (AVR) system, and a list of tips for correcting the most common dental claim denials. The Dental Program website also includes links to those Medicaid forms that are most often used by dental providers. Please let us know if you have suggestions for other helpful links that could be included.
Dr. Ron Venezie, Dental Director
DMA, 919-855-4280
In order to comply with the Centers for Medicare and Medicaid Services’ coding changes, codes A4323, sterile saline, 1000 ml, and K0409, sterile water, 1000 ml, will be end-dated on November 30, 2004. They will be replaced with code A4217, sterile water/saline, 500 ml.
Effective with date of service December 1, 2004, providers must bill for sterile water/saline with code A4217. The maximum reimbursement rate will be $2.66. Prior approval is not required. However, a Certificate of Medical Necessity and Prior Approval form must be completed regardless of the requirement for prior approval.
EDS, 1-800-688-6696 or 919-851-8888
Reimbursement Rate Increase for Private Duty Nursing Services
Effective with date of service October 1, 2004, the Medicaid maximum reimbursement rate for In-Home Private Duty Nursing is being changed to $9.11 per 15 minute unit. This is an annual rate increase per the State Plan.
Effective with date of service November 30, 2004, the following HCPCS codes will be end-dated to comply with the national standard codes mandated by the Health Insurance Portability and Accountability Act (HIPAA). The new codes will become effective December 1, 2004.
HCPCS Code List
|
Current |
New |
Description |
Billing |
Maximum Reimbursement Rate |
|---|---|---|---|---|
|
A4214 |
A4216 |
Sterile /saline or water, 10ml |
10ml |
$ .40 |
|
A4323 |
A4217 |
Sterile /saline or water, 500ml |
500ml |
2.66 |
|
A4621 |
A7525 |
Tracheostomy mask each |
Each |
2.07 |
|
A7526 |
Tracheostomy tube, collar and holder |
Each |
3.37 |
|
|
A4622 |
A7520 |
Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal each |
Each |
47.48 |
|
A7521 |
Tracheostomy/laryngectomy tube, cuffed polyvinylchloride (pvc), sil1cone or equal each. |
Each |
47.05 |
|
|
A7522 |
Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable or reusable), each |
Each |
45.16 |
|
|
A6422 |
A6443 |
Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to three inches and less than 5 inches, per yard |
Per yard |
.29 |
|
A6424 |
A6444 |
Conforming bandage, non-elastic, knitted/woven, nonsterile greater than or equal to five inches per yard. |
Per yard |
.56 |
|
A6426 |
A6446 |
Conforming bandage, nonelastic, knitted/woven, sterile, width greater than or equal to three inches and less than 5 inches, per yard |
Per yard |
.41 |
|
A6428 |
A6447 |
Conforming bandage, nonelastic, knitted/woven, sterile, greater than or equal to five inches per yard |
Per yard |
.67 |
|
A6430 |
A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than 5 inches, per yard |
Per yard |
1.75 |
|
A6432 |
A6450 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to 5 inches, per yard |
Per yard |
1.00 |
|
A6440 |
A6456 |
Zinc paste impregnated bandage, nonelastic, knit/woven, width greater than or equal to 3 inches and less than 5 inches, per yard |
Per yard |
1.28 |
|
B4084 |
B4086 |
Gastrostomy/jejunostomy tube any type |
Each |
17.09 |
|
K0621 |
A6407 |
Packing strips, non-impregnatal, up to 2 inched wide |
Each |
1.88 |
|
S8181 |
See A7526 Above |
Tracheostomy tube, collar and holder |
Each |
3.37 |
|
W4651 |
Use current code A4253 |
Blood glucose test strips |
50/pkg |
33.22 |
EDS, 1-800-688-6696 or 919-851-8888
The Home Health Fee Schedule has been updated to reflect the following rates for all home health visits. The update is effective for dates of service July 1, 2004. EDS will generate automated adjustments for claims processed and paid at the old rate. Providers do not need to submit adjustment requests.
|
Revenue Code |
Home Health Services |
Billing Unit |
Maximum Rate Reimbursement |
|---|---|---|---|
|
420 |
Physical Therapy |
1 visit |
$99.94 |
|
424 |
Physical Therapy - Evaluation |
1visit |
99.94 |
|
430 |
Occupational Therapy |
1 visit |
99.94 |
|
434 |
Occupational Therapy - Evaluation |
1visit |
99.94 |
|
440 |
Speech Therapy |
1 visit |
99.94 |
|
444 |
Speech Therapy - Evaluation |
1visit |
99.94 |
|
550 |
Observation/Evaluation of stable patient |
1 visit |
101.41 |
|
551 |
Skilled Nursing Visit Prefilling insulin syringes |
1 visit |
101.41 |
|
559 |
Skilled Nursing Visit for Prefilling medicine planners |
1 visit |
101.41 |
|
570 |
Home Health Aide |
1 visit |
46.39 |
|
580 |
Skilled Nursing Visit for Venipuncture |
1 visit |
101.41 |
|
581 |
Skilled Nursing Visit for Denied by Medicare for dually-eligible patient |
1 visit |
101.41 |
|
589 |
Skilled Nursing Visit meeting Medicare criteria |
1 visit |
101.41 |
|
590 |
Skilled Nursing Visit/Not Otherwise Classified |
1 visit |
101.41 |
EDS, 1-800-688-6696 or 919-851-8888
The N.C. Medicaid program does not routinely cover observation charges for hysterectomies. These charges are covered only in situations where a patient exhibits an uncommon or unusual reaction or other postoperative complications that require monitoring or treatment beyond the usual provided in the immediate post operative period. When observation charges are billed and no records are included with the claim, the claim will be denied for medical records to substantiate necessity for the service. Providers will receive the denial EOB 1396 "Observation is not routinely allowed. Submit records to review for medical necessity, include: History and Physical, Operative records, Pathology report and Discharge summary."
EDS 1-800-688-6696 or 919-851-8888
Effective with date of service September 17, 2004, the rates for some services provided by the Independent Practitioners Program were changed. Below is a list of the changes.
Refer to Clinical Policy #10B (previously numbered as #8G) for additional information and for a complete list of billing codes.
Note: Not all rates are changing at this time. Please refer to future bulletin articles for further information. Providers should continue to bill their usual and customary charges.
|
Procedure Code |
Maximum Reimbursement Rate |
|---|---|
|
29075 |
$ 69.79 |
|
29085 |
74.33 |
|
29105 |
72.68 |
|
29125 |
55.15 |
|
29126 |
68.14 |
|
29130 |
33.91 |
|
29131 |
44.49 |
|
29240 |
54.90 |
|
29260 |
45.37 |
|
29280 |
45.93 |
|
29405 |
72.21 |
|
29425 |
78.52 |
|
29505 |
63.99 |
|
29515 |
55.72 |
|
29530 |
47.73 |
|
29540 |
32.73 |
|
31502 |
73.36 |
|
31720 |
87.02 |
|
92065 |
31.39 |
|
92510 |
123.43 |
|
92526 |
74.77 |
|
92551 |
9.69 |
|
92552 |
15.41 |
|
92567 |
18.49 |
|
92569 |
14.09 |
|
92571 |
13.43 |
|
92572 |
3.19 |
|
92576 |
15.63 |
|
92583 |
31.14 |
|
92587 |
52.81 |
|
92588 |
70.00 |
|
92590 |
39.94 |
|
92591 |
59.99 |
|
92592 |
17.56 |
|
92593 |
26.31 |
|
92594 |
18.98 |
|
92595 |
28.82 |
|
92610 |
115.35 |
|
94010 |
28.81 |
|
94060 |
49.52 |
|
94150 |
18.77 |
|
94200 |
19.09 |
|
94240 |
32.00 |
|
94375 |
31.80 |
|
94657 |
63.34 |
|
95831 |
21.38 |
|
95832 |
18.76 |
|
95833 |
31.75 |
|
95834 |
38.23 |
|
97010 |
4.00 |
|
97012 |
13.71 |
|
97016 |
12.88 |
|
97018 |
5.98 |
|
97020 |
4.33 |
|
97022 |
13.51 |
|
97024 |
5.32 |
|
97026 |
4.33 |
|
97028 |
5.37 |
|
97032 |
14.37 |
|
97033 |
18.91 |
|
97034 |
12.95 |
|
97035 |
11.30 |
|
97036 |
21.05 |
|
97110 |
26.09 |
|
97112 |
26.31 |
|
97116 |
22.55 |
|
97124 |
20.23 |
|
97140 |
24.28 |
|
97504 |
27.74 |
|
97520 |
25.65 |
|
97530 |
26.61 |
|
97533 |
23.75 |
|
97535 |
27.30 |
|
97542 |
25.43 |
|
97601 |
35.01 |
|
97602 |
15.77 |
|
97703 |
22.85 |
|
97750 |
26.31 |
Laurie Edwards, Financial Management
DMA, 919-855-4200
Effective with date of service September 17, 2004, the rates for some services provided by Local Education Agencies (LEAs) were changed. Below is a list of the changes. This table replaces information published in the April 2004 general Medicaid bulletin.
The below are maximum reimbursement rates; however, providers must bill their usual and customary charges. Schools that bill Medicaid are only paid the federal share of the Medicaid reimbursement rate listed below. Reimbursement rates will change as the Federal Financial Participation (FFP) percentage changes.
Refer to the Clinical Coverage Policy #10C (previously numbered at 8H) for additional information on billing for LEA services and a complete list of billing codes.
Note: Not all rates are changing at this time. Please refer to future bulletin articles for further information.
|
Procedure Code |
Maximum Reimbursement |
|---|---|
|
29075 |
$ 69.79 |
|
29085 |
74.33 |
|
29105 |
72.68 |
|
29125 |
55.15 |
|
29126 |
68.14 |
|
29130 |
33.91 |
|
29131 |
44.49 |
|
29240 |
54.90 |
|
29260 |
45.37 |
|
29280 |
45.93 |
|
29405 |
72.21 |
|
29505 |
63.99 |
|
29515 |
55.72 |
|
29530 |
47.73 |
|
29540 |
32.73 |
|
90801 |
139.49 |
|
90802 |
148.15 |
|
90804 |
59.98 |
|
90806 |
90.19 |
|
90808 |
134.73 |
|
90810 |
64.21 |
|
90812 |
97.28 |
|
90814
|
141.27
|
|
90846
|
87.47
|
|
90853
|
29.40
|
|
92065
|
31.39
|
|
92510
|
123.43
|
|
92526
|
74.77
|
|
92551
|
9.69
|
|
92552
|
15.41
|
|
92567
|
18.49
|
|
92569
|
14.09
|
|
92572
|
3.19
|
|
92576
|
15.63
|
|
92583
|
31.14
|
|
92585
|
89.93
|
|
92587
|
52.81
|
|
92588
|
70.00
|
|
92590
|
39.94
|
|
92591
|
59.99
|
|
92592
|
17.56
|
|
92593
|
26.31
|
|
92594
|
18.98
|
|
92595
|
28.82
|
|
95831 |
21.38 |
|
95832 |
18.76 |
|
95833 |
31.75 |
|
95834 |
38.23 |
|
96100 |
62.40 |
|
96110 |
10.22 |
|
96111 |
131.50 |
|
96115 |
62.40 |
|
96117 |
62.40 |
|
97110 |
26.09 |
|
97112 |
26.31 |
|
97116 |
22.55 |
|
97140 |
24.28 |
|
97504 |
27.74 |
|
97520 |
25.65 |
|
97530 |
26.61 |
|
97533 |
23.75 |
|
97535 |
27.30 |
|
97542 |
25.43 |
|
97703 |
22.85 |
|
97750 |
26.31 |
Laurie Edwards, Financial Management
DMA, 919-855-4200
Seminars for the expansion of provider types for Outpatient Behavioral Health Services are scheduled for December 2004. This seminar will focus on the expansion of access to services for Medicaid eligible recipients by increasing the provider community and the age group that they serve.
Providers are encouraged to arrive 30 minutes before the seminar begins to complete registration. Unregistered providers are welcome to attend if space is available. No food or drinks will be provided.
Providers may register for the seminars by completing and submitting the Outpatient Behavioral Health Services Registration form or through by Online Registration.
The December 2004 Special Bulletin VII, Outpatient Behavioral Health Services Provided by Direct Enrolled Providers, will be used as the primary training document for the seminar. The special bulletin will be available on DMA’s website beginning December 2004 at http://www.dhhs.state.nc.us/dma/bulletin.htm. Please print the special bulletin and bring it to the seminar.
|
Tuesday, Decemer 7, 2004 Park Inn Gateway Conference Center |
Wednesday, December 8, 2004 Blue Ridge Community College |
|
Thursday, December 9, 2004 Greenville Hilton
|
Friday, December 10, 2004 Wake Med Andrews Conference Center |
Park Inn Gateway Conference Center – Hickory, North Carolina
Take I-40 to exit 123. Follow signs to Highway 321 North. Take the first exit (Hickory exit) and follow the ramp to the stoplight. Turn right at the light onto Highway 70. The Gateway Conference Center is on the right.
Blue Ridge Community College, Bo Thomas Auditorium – Flat Rock, North Carolina
Take I-40 to Asheville. Travel east on I-26 to exit 22. Turn right and then take the next right. Follow the signs to Blue Ridge Community College. Turn left at the large Blue Ridge Community College sign. The college is located on the right. Take the first right-hand turn into the parking lot for the Bo Thomas Auditorium.
Greenville Hilton – Greenville, North Carolina
Take Highway 264 east to Greenville. Turn right onto Allen Road in Greenville. Travel approximately 2 miles. Allen Road becomes Greenville Boulevard/Alternate 264. Follow Greenville Boulevard for 2½ miles to the Hilton Greenville, which is located on the right.
WakeMed Andrews Conference Center – Raleigh, North Carolina
Take the I-440 Raleigh Beltline to exit 13A, New Bern Avenue.
Paid parking ($3.00 maximum per day) is available on the top two levels of parking deck P3. To reach the parking deck, turn left at the fourth stoplight on New Bern Avenue, and then turn left at the first stop sign. Parking for oversized vehicles is available in the overflow lot for parking deck P3. Handicapped accessible parking is available in parking lot P4, directly in front of the conference center.
To enter the Andrews Conference Center, follow the sidewalk toward New Bern Avenue past the Medical Office Building to entrance E2 of the William F. Andrews Center for Medical Education. A map of the WakeMed campus is available online at http://www.wakemed.org.
Illegally parked vehicles will be towed. Parking is not permitted at East Square Medical Plaza, Wake County Human Services or in parking lot P4 (except for handicapped accessible parking).
EDS, 1-800-688-6696 or 919-851-8888
On October 1, 2004, the Division of Medical Assistance (DMA) will begin a new Medical Data Sets (MDS) Validation Program as a component of the Medicaid Case Mix Reimbursement System. All facilities participating in the Medicaid Case Mix Reimbursement System are required to participate in the MDS Validation Program. The overall goal of the Case Mix Reimbursement System is to align payments with the level of care needed by the residents in the facility. Completion of the MDS reports is a very important function of the nursing facility staff and ensures that the nursing facility receives accurate payments from the N.C. Medicaid program.
The MDS Validation Program provides DMA and the nursing facility with assurance that the Medicaid payments are accurately based on the recorded medical and functional needs of the nursing facility resident as documented in the medical record. The MDS Validation Program replaces the FL2 and FL12 utilization review program performed by the facility staff and contract physicians, which was discontinued as of September 30, 2003.
DMA has contracted with Myers and Stauffer, LLP, to provide registered nurse reviewers to conduct onsite MDS reviews of each nursing facility in North Carolina. The reviews were scheduled to begin on October 1, 2004. All of the reviews will be completed by September 30, 2005. This first year (October 1, 2004 through September 30, 2005) of reviews are considered as educational reviews and are intended to assist facility staff in understanding the process and the requirements for MDS supportive documentation.
Important Definitions for the MDS Validation Program
RUG-III Reimbursement System – Medicaid uses the RUG III system to assign the facility Case Mix Index (CMI) rate. RUG III groups classify residents into 34 groups that use similar quantities of resources defined as nursing time, therapy time, and nursing assistant time. There are 108 MDS 2.0 elements that determine the RUG III classification system.
Case Mix – refers to a combination of different individual resident profiles seen in a specific setting or facility.
Case Mix Index (CMI) – each RUG-III group is assigned a weight, or numeric score, which reflects the relative resources predicted to provide care to the resident. The higher the case mix index, the greater the resource requirement for the resident.
Resident Roster – identifies all non-discharged residents and includes information on the MDS RUG-III elements transmitted on the sample set of assessments. In addition, it provides a summary of the number of MDS records in each RUG-III category.
Supportive Documentation Guidelines
DMA uses the Supportive Documentation Guidelines approved by the Centers for Medicare and Medicaid Services (CMS) to define the supporting documentation necessary to verify a RUG-III item during an MDS review.
MDS Validation Program Protocols
1. The list of residents or resident roster is produced on a Case Mix Index Report (CMI Report) every quarter on the "snapshot date" and sent to the facility. The "snapshot dates" are March 31, June 30, September 30, and December 31. For a facility review occurring in October 2004, the review sample will be drawn from the CMI Report dated June 30, 2004. For a facility review, occurring in February 2005, the review sample will be drawn from the CMI Report of residents in the facility dated September 30, 2004.
2. The sample will be drawn from all residents listed on the final CMI report regardless of payer source.
3. Both the primary and expanded samples shall include a minimum of 80 percent Medicaid recipients.
4. In the second year of case mix reviews, facilities will experience an expanded review when the primary assessment sample results in an unsupported percent are equal to or greater than the state threshold. This expanded review will include an additional 10 percent of the residents on the final CMI report or an additional 10 assessments, whichever is greater.
5. The results of the MDS Validation Program may result in re-rugging and a change in the case mix index rate for the nursing facility, as defined below.
MDS Review Process
1. Nursing facilities will be notified by the contract nurse reviewers both by phone and by fax three (3) business days prior to the visit.
2. An entrance conference will be held with the nursing facility administrator, the MDS coordinator, and any other facility personnel the administrator selects to discuss the overall objectives of the review and to allow the facility personnel to ask questions.
3. The nurse reviewer will prepare a list of the MDS's and resident records selected for review and ask the facility personnel to pull the records. If possible, the primary sample will include at least one assessment from each of the seven RUG-III classification groups.
4. The review begins immediately after the entrance conference. The reviewers will use the MDS documentation guidelines as issued by CMS (http://www.cms.hhs.gov/medicaid).
5. The reviewer will verify the MDS items and determine if the RUG-III category reported on the Final Case Mix Report is supported with documentation in the medical record.
6. Documentation for the activities of daily living (ADL's) must reflect 24/7 of the observation periods to verify the submitted values on the MDS.
7. Immediately following the review of the MDS assessments, the medical records, and other supportive documentation, the nurse reviewers will hold an exit interview with the facility staff to review preliminary results. Any unresolved issues or trends will be identified and discussed.
8. No supporting documentation will be accepted after the close of the exit conference.
9. A case mix review summary letter will be mailed to the provider by the nurse reviewers from Myers and Stauffer indicating the results of the review.
10. DMA reserves the right to conduct follow-up reviews as needed. These reviews would occur no earlier than 120 days following the exit interview.
Delinquent MDS Assessment:
Any assessment with an R2b date greater than 121 days from the previous R2b date will be deemed delinquent and assigned a RUG-III code of BC1, which is the lowest possible case mix index.
Unsupported MDS Assessment
The MDS is unsupported when the MDS nurse reviewers do not find adequate documentation for the RUG-III Classification level in the patient record. An unsupported MDS assessment can result in a different RUG-III classification from the one submitted by the facility.
Effect of Unsupported Thresholds
The following resources are available to facility staff for questions related to the MDS and MDS Validation Program
MDS State Contact – For all questions related to coding.
Cindy DePorter, Division of Facility Services
919-715-1872, ext. 214
MDS Help Desk
919-715-1872
QUIESHELPDESK@ncmail.net
Myers and Stauffer’s Help Desk – For questions other
than coding issues.
Documentation Guidelines
1-800-763-2278
MDS Validation Program Oversight and Administration
Margaret Comin, RN, Facility Unit Manager
DMA, 919-855-4350
The following table lists the FDA-approved-drugs currently covered by the N.C. Medicaid program when the drugs are provided in a physician’s office for the FDA-approved indications. This list replaces all previously published lists. Rates are effective with the April 1, 2004 date of service and reflect a change to 90 percent AWP. Since the effect is both increases and decreases to the rates, systematic adjustments will be made to align paid claims with these fees retroactive to April 1, 2004 for claims paid between April 1, 2004 and implementation of these rates.
Physicians will continue to bill on the CMS-1500 claim form using the appropriate drug code and indicating the specified number of units administered. Providers must bill their usual and customary charges.
An asterisk (*) indicates that an invoice must be submitted with the CMS-1500 claim form. An invoice must be submitted with each claim. The paper invoice must indicate the name of the recipient, the recipient’s Medicaid identification number, the name of the medication, the dosage given, the National Drug Code (NDC) number from the vial(s) used, the number of vials used, and the cost per dose. Providers must indicate the number of units given in block 24G on the CMS-1500 claim form. Payment is based in accordance with Medicaid’s State Plan for reimbursement. Providers will be reimbursed the lower of the invoice price or maximum allowable fee on file.
Injectable Drug List
|
Invoice Required |
Procedure Code |
Description |
Maximum Reimbursement Rate |
|---|---|---|---|
|
|
J0130 |
Abciximab 10 mg |
$486.02 |
|
|
J1120 |
Acetazolamide Sodium, up to 500 mg (Diamox) |
19.44 |
|
J0150 |
Adenosine I.V., 6 mg (Adenocard) |
36.85 |
|
|
|
J0152 |
Adenosine, 30 mg (Adenoscan) |
72.40 |
|
|
J0170 |
Adrenalin, Epinephrine, up to 1 ml ampule |
2.22 |
|
* |
J3490 |
Agalsidase Beta, 1mg (Fabrazyme) |
4500.00 |
|
|
P9047 |
Albumin (human), 25%, 50 ml |
52.20 |
|
|
P9041 |
Albumin (human), 5%, 50 ml |
13.78 |
|
|
J9015 |
Aldesleukin, per single use vial (Proleukin, IL-2, Interleukin) 22 million I.U. |
695.81 |
|
|
J0215 |
Alefacept 0.5 mg, injection (Amevive) |
29.85 |
|
|
J0205 |
Alglucerase, per 10 units (Ceredase) |
35.56 |
|
|
J0256 |
Alpha 1 Proteinase Inhibitor Human A, 10 mg (Prolastin) |
2.52 |
|
|
J2997 |
Alteplase recombinant, 1 mg |
34.77 |
|
|
J0207 |
Amifostine 500 mg (Ethyol) |
429.13 |
|
|
S0072 |
Amikacin Sulfate (100 mg) |
14.06 |
|
|
S0016 |
Amikacin Sulfate 500 mg (Amikin) |
16.88 |
|
|
J0280 |
Aminophyllin, up to 250 mg |
1.00 |
|
|
J1320 |
Amitriptyline HCL, up to 20 mg (Elavil, Enovil) |
2.28 |
|
|
J0300 |
Amobarbital, up to 125 mg (Amytal) |
2.52 |
|
|
J0288 |
Amphotericin B cholesteryl sulfate complex, 10 mg |
14.40 |
|
|
J0287 |
Amphotericin B lipid complex, 10 mg |
20.70 |
|
|
J0289 |
Amphotericin B liposome, 10 mg |
33.91 |
|
|
J0285 |
Amphotericin B, 50 mg (Amphocin, Fungizone IV) |
10.48 |
|
|
J0295 |
Ampicillin Sodium/Sulbactam Sodium, per 1.5 gm (Unasyn) |
7.03 |
|
|
J0290 |
Ampicillin, up to 500 mg (Omnipen-N, Totacillin-N) |
1.57 |
|
|
J0350 |
Anistreplase, per 30 units (Eminase) |
2552.02 |
|
|
J7197 |
Antithrombin II (human) per I.U. (Throbate III) |
1.19 |
|
|
J0395 |
Arbutamine HCL, 1 mg (GenESA) |
172.80 |
|
|
J9017 |
Arsenic Trioxide 1mg (Trisenox) |
35.10 |
|
|
J9020 |
Asparaginase, 10,000 units (Elspar) |
59.32 |
|
|
J0460 |
Atropine Sulfate, up to 0.3 mg |
0.78 |
|
|
J2910 |
Aurothioglucose, up to 50 mg (Solganal) |
16.40 |
|
|
J0456 |
Azithromycin, 500 mg. (Zithromax) |
24.20 |
|
|
Q0144 |
Azithromycin, oral suspension 1 unit = 1 gm packet (Zithromax), only oral drug on list |
23.02 |
|
|
J0476 |
Baclofen, for intrathecal trial, 50 mcg (Lioresal for intrathecal trial) |
75.60 |
|
|
J0475 |
Baclofen, Kit 1*20 ml. Amp. (10 mg/20ml. 500 meg/ml.) |
221.40 |
|
* |
J3490 |
Baclofen, Kit 2*5 ml. Amp. (10 mg./5 ml. 2000 meg/ml.) |
464.40 |
|
* |
J3490 |
Baclofen, Kit 4*5 ml. Amp. (10 mg./5ml. 2000 meg/ml.) |
815.40 |
|
|
J9031 |
BCG live (intravesical) per installation (Tice, TheraCys) |
151.70 |
|
|
J0702 |
Betamethasone Acetate and Betamethasone Sodium Phosphate, per 3 mg |
4.72 |
|
|
J0704 |
Betamethasone Sodium Phosphate, per 4 mg |
1.02 |
|
|
J0520 |
Bethanechol Chloride, mytonachol or urecholine, up to 5 mg (Urecholine) |
5.06 |
|
|
J9040 |
Bleomycin Sulfate, 15 units (Blenoxane) |
172.80 |
|
|
S0115 |
Bortezomib 3.5 mg (Velcade) |
1076.63 |
|
|
J0585 |
Botulinum toxin type A, per unit (Botox) |
4.69 |
|
|
J0945 |
Brompheniramine Maleate, 10mg |
0.90 |
|
|
J0595 |
Butorphanol Tartrate, 1mg (Stadol) |
4.17 |
|
|
J0636 |
Calcitriol, 0.1 mcg (Calcijex) |
1.31 |
|
|
J0610 |
Calcium Gluconate, per 10 ml (Kaleinate) |
0.96 |
|
|
J0620 |
Calcium Glycerophosphate and Calcium Lactate, per 10 ml (Calphosan) |
6.08 |
|
|
J9045 |
Carboplatin, 50 mg (Paraplatin) |
140.92 |
|
|
J9050 |
Carmustine, 100 mg (BiCNU) |
129.01 |
|
|
J0690 |
Cefazolin Sodium, 500 mg (Ancef, Kefzol, Zolicef) |
2.13 |
|
|
J0692 |
Cefepime HCL, 500 mg (Maxiprene) |
7.70 |
|
|
J0698 |
Cefotaxime Sodium, per gm (Claforan) |
9.90 |
|
|
J0694 |
Cefoxitin Sodium, 1 gm (Mefoxin) |
10.13 |
|
|
J0713 |
Ceftazidime per 500 mg (Fortaz, Tazidime) |
6.40 |
|
|
J0715 |
Ceftizoxime Sodium, per 500 mg (Cefizox) |
4.70 |
|
|
J0696 |
Ceftriaxone Sodium, per 250 mg (Rocephin) |
14.14 |
|
|
J0697 |
Cefuroxime Sodium, per 750 mg (Kefurox, Zinacef) |
6.08 |
|
|
J1890 |
Cephalothin Sodium, up to 1 gm (Keflin) |
9.72 |
|
|
J0710 |
Cephapirin Sodium, up to 1 gm (Cefadyl) |
1.33 |
|
J0720 |
Chloramphenicol Sodium Succinate, up to 1 gm |
6.84 |
|
|
|
J1990 |
Chlordiazepoxide HCL, up to 100 mg (Librium) |
23.68 |
|
|
J0390 |
Chloroquine HCL, up to 250 mg (Aralen) |
18.65 |
|
|
J1205 |
Chlorothiazide Sodium, 500 mg (Diuril Sodium) |
9.94 |
|
|
J2400 |
Chlorprocaine HCL 30 ml (Nesacaine, Nesacaine-MPF) |
6.06 |
|
|
J3230 |
Chlorpromazine HCL up to 50 mg (Thorazine) |
4.17 |
|
|
J0725 |
Chorionic Gonadotropin, per 1,000 USP units |
2.93 |
|
|
J0740 |
Cidofovir 375 mg (Vistide) |
799.20 |
|
|
J0743 |
Cilastatin Sodium Imipenem, per 250 mg (Primaxin IM, Primaxin IV) |
15.04 |
|
|
S0023 |
Cimetadine HCL, 300 mg (Tagamet) |
1.34 |
|
|
J0744 |
Ciprofloxacin for IV infusion, 200 mg (Cipro) |
12.97 |
|
|
J9062 |
Cisplatin, 50 mg (Platinol AQ) |
75.60 |
|
|
J9060 |
Cisplatin, powder or solution, per 10 mg (Platinol, Plantinol AQ) |
15.12 |
|
|
J9065 |
Cladribine, per 1 mg (Leustatin) |
48.60 |
|
|
J0735 |
Clonidine Hydrochloride, 1 mg |
52.25 |
|
|
J0745 |
Codeine Phosphate, per 30 mg |
0.48 |
|
|
J0760 |
Colchicine, 1 mg |
6.70 |
|
|
J0770 |
Colistimethate Sodium, up to 150 mg (Coly-Mycin M) |
51.30 |
|
|
J0800 |
Corticotropin, up to 40 units (Acthar, ACTH) |
88.05 |
|
|
J0835 |
Cosyntropin, per 0.25 mg (Cortrosyn) |
17.28 |
|
|
J3420 |
Cyanocobalamin, vitamin B 12, 1000 mcg |
0.13 |
|
|
J9096 |
Cyclophosphamide Lyophilized 1 gm (Cytoxan Lyophilized) |
46.29 |
|
|
J9093 |
Cyclophosphamide Lyophilized, 100 mg (Cytoxan Lyophilized) |
5.29 |
|
|
J9097 |
Cyclophosphamide Lyophilized, 2gm |
92.60 |
|
|
J9091 |
Cyclophosphamide, 1.0 gm (Cytoxan, Neosar) |
43.33 |
|
|
J9070 |
Cyclophosphamide, 100 mg (Cytoxan, Neosar) |
5.43 |
|
|
J9092 |
Cyclophosphamide, 2.0 gm (Cytoxan, Neosar) |
86.63 |
|
|
J9080 |
Cyclophosphamide, 200 mg (Cytoxan, Neosar) |
10.31 |
|
|
J9090 |
Cyclophosphamide, 500 mg (Cytoxan, Neosar) |
21.65 |
|
|
J9094 |
Cyclophosphamide, Lyophilized, 200 mg (Cytoxan Lyophilized) |
10.58 |
|
|
J9095 |
Cyclophosphamide, Lyophilized, 500 mg (Cytoxan Lyophilized) |
23.14 |
|
|
J9100 |
Cytarabine 100 mg (Cytosar-U) |
3.02 |
|
|
J9110 |
Cytarbine, 500 mg (Cytosar-U) |
8.10 |
|
|
J7070 |
D5W, 1000 cc |
10.40 |
|
|
J9130 |
Dacarbazine 100 mg (DTIC-Dome) |
12.02 |